Cotización Crossject - ALCJ

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

1.77

Postura de Compra

1.77

Postura de Venta

1.79

Volume Operado de la Acción

82,728

1.75 Rango del Día 1.82

1.52 Rango de 52 semanas 3.495

Capitalización de Mercado [m]

65.071M

Precio Anterior

1.826

Precio de Apertura

1.81

Hora

1.77

Última hora de negociación

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

89,309

Acciones en circulación

36,763,256

Rendimiento del Dividendo

Ratio Precio/Utilidad

-7.53

Beneficio por acción (BPA)

-0.24

turnover

9.14M

Beneficio neto

-8.64M

Sector

Med, Dental, Hosp Eq-whsl

Industria

Med, Dental, Hosp Eq-whsl

Sitio web

www.crossject.com

Sede

Dijon, Cote-d'or, Fra

Fundado

Crossject is listed in the Med, Dental, Hosp Eq-whsl sector of the Euronext with ticker ALCJ. The last closing price for Crossject was 1.83 €. Over the last year, Crossject shares have traded in a share price range of 1.52 € to 3.495 €.

Crossject currently has 36,763,256 shares in issue. The market capitalisation of Crossject is 67.13 € million. Crossject has a price to earnings ratio (PE ratio) of -7.53.

CROSSJECT franchit une étape clé dans la stabilité des lots produits de ZEPIZURE®

CROSSJECT franchit une étape clé dans la stabilité des lots produits de ZEPIZURE® Communiqué de presse CROSSJECT franchit une étape clé dans la...

CROSSJECT achieves key ZEPIZURE® manufacturing batch stability milestones

CROSSJECT achieves key ZEPIZURE® manufacturing batch stability milestones Press Release CROSSJECT achieves key ZEPIZURE® manufacturing batch...

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social Communiqué de Presse Information...

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social Communiqué de Presse Information...

Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board

Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board Dijon, FRANCE...

Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board

Dijon, FRANCE, February 12, 2025 – 0730 (CET) – Crossject (ISIN: FR0011716265; Euronext Growth : ALCJ), a...

Crossject annonce le renouvellement de Patrick Alexandre et Isabelle Liebschutz dans leurs fonctions de membres d’un nouveau Directoire ressérré

Crossject annonce le renouvellement de Patrick Alexandre et Isabelle Liebschutz dans leurs fonctions de membres d’un nouveau Directoire ressérré...

COMPLETION OF THE TRANSACTIONS ANNOUNCED IN DECEMBER 2024 RELATING TO THE AMENDMENT OF THE CONVERTIBLE BONDS SUBSCRIBED BY AN ENTITY AFFILIATED TO HEIGHTS CAPITAL MANAGEMENT, INC. (“HEIGHTS”) AND THE ISSUE OF A SECOND ASSIMILABLE TRANCHE

COMPLETION OF THE TRANSACTIONS ANNOUNCED IN DECEMBER 2024 RELATING TO THE AMENDMENT OF THE CONVERTIBLE BONDS SUBSCRIBED BY AN ENTITY AFFILIATED TO...

Réalisation des opérations annoncées en décembre 2024 relatives a la modification des obligations convertibles souscrites par une entité affiliée à Heights Capital Management, Inc. (« Heights ») et l’émission d’une seconde tranche assimilab

Réalisation des opérations annoncées en décembre 2024 relatives a la modification des obligations convertibles souscrites par une entité affiliée...

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social Communiqué de Presse Information...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.106	-5.65031982942	1.876	1.96	1.75	80344	1.86998223	DE
4	0.026	1.49082568807	1.744	2.075	1.734	81063	1.88491916	DE
12	-0.3	-14.4927536232	2.07	2.25	1.68	89309	1.94423165	DE
26	-0.665	-27.3100616016	2.435	2.75	1.66	87748	2.04817967	DE
52	-1.725	-49.356223176	3.495	3.495	1.52	82796	2.05847114	DE
156	-0.35	-16.5094339623	2.12	5.96	1.52	84726	3.23047871	DE
260	0.53	42.7419354839	1.24	5.96	1.185	128120	3.08300621	DE

ALCJ - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Crossject?

El precio actual de las acciones de Crossject es 1.77 €

¿Cuántas acciones de Crossject están en circulación?

Crossject tiene 36,763,256 acciones en circulación

¿Cuál es la capitalización de mercado de Crossject?

La capitalización de mercado de Crossject es EUR 67.13M

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Crossject?

Crossject ha negociado en un rango de 1.52 € a 3.495 € durante el último año

¿Cuál es el ratio PE (precio/beneficio) de Crossject?

El ratio precio/beneficio de Crossject es -7.53

¿Cuál es el ratio de efectivo a ventas de Crossject?

El ratio de efectivo a ventas de Crossject es 7.12

¿Cuál es la moneda de reporte de Crossject?

Crossject presenta sus resultados financieros en EUR

¿Cuál es el último ingresos anual de Crossject?

El último ingresos anual de Crossject es EUR 9.14M

¿Cuál es el último beneficio anual de Crossject?

El último beneficio anual de Crossject es EUR -8.64M

¿Cuál es la dirección registrada de Crossject?

La dirección registrada de Crossject es 6 RUE PAULINE KERGOMARD - ZAC PARC MAZEN SULLY, DIJON, COTE-D'OR, 21000

¿Cuál es la dirección del sitio web de Crossject?

La dirección del sitio web de Crossject es www.crossject.com

¿En qué sector industrial opera Crossject?

Crossject opera en el sector MED, DENTAL, HOSP EQ-WHSL

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
CLEXCumulex NV	0.88 € (43.09%)	100
MLOCTOctopus Biosafety	0.134 € (34.00%)	101
MLWEYWeya	0.019 € (26.67%)	3.25k
ALEUPEuroplasma	0.0138 € (24.32%)	97.44M
POXELPoxel	0.22 € (24.29%)	5.01M
ALKLAKlarsen	0.761 € (-50.90%)	493.15k
ALCYBCybergun	0.0001 € (-50.00%)	68.51M
SGDDSSpineguard DS	0.0001 € (-50.00%)	778.85k
DMSBSDiagnostic Medical Systems	0.005 € (-50.00%)	3k
HAFDSHaffner Energy DS	0.013 € (-39.53%)	278.57k
ATOAtos SE	0.004 € (8.11%)	1.16B
BCPBanco Comercial Portugues SA	0.5448 € (-0.91%)	152.4M
ALALOAcheterLouerFR	0.0022 € (4.76%)	99.26M
ALEUPEuroplasma	0.0138 € (24.32%)	97.44M
ALCYBCybergun	0.0001 € (-50.00%)	68.51M

NASDAQ2020 2 minutos hace

5 TO 10 BAGGER FOR BUY OUT

ELTP

ELTP

Bill2 4 minutos hace

Shoon you are great basher, I knew that all the bashing in the last few days tell me that we were going to get great news very soon, Instead going to trip zeros we will going up to double digits. The CEO is a great man.
Keep bashing we are a looser. Monday we will go up look at the trading y

MGON

ecmoney 6 minutos hace

I really like Ngmc

Look into this one read my post

If they get a Vlokr app is going up

Ec

ICON

ilovetech 7 minutos hace

Dude he didn't say that -

What you're trying to tell us is that DCVax-L won't get approval using artisan manufacturing, which is utter nonsense.

He said:

You missed my point. Artisan is going to be used first BUT it was never going to be the longer term s

NWBO

Anvil 7 minutos hace

https://www.whitehouse.gov/presidential-actions/2025/03/immediate-measures-to-increase-american-mineral-production/

PDIV

Anvil 9 minutos hace

https://www.whitehouse.gov/presidential-actions/2025/03/immediate-measures-to-increase-american-mineral-production/

GNCP

Mac1957 9 minutos hace

https://www.hydrogeninsight.com/innovation/more-than-1-000km-without-stopping-first-100kg-liquid-hydrogen-truck-system-successfully-tested-in-china/2-1-1795913

PLUG

stockanalyze 11 minutos hace

maybe you deserve it after 17 years and missing opoortunities where stocks have tripled or went 20x, 200x, look at tesla with a pe over 100, look at amazon, apple, nvidia, microsoft all over 3 trillion. these two need to be over 3 trillion.absoultely over 3 trillion in market cap where they provide

FNMA

B RY 11 minutos hace

(Updated)Morning wayne, thanks! I had to go to MULN youtube to see the full name of the song. I wasn't familiar with that bob dylan classic. Joni Mitchell was an amazing artist/songwriter and I may be wrong, but I am under the impression bob dylan didn't treat her properly. I never cared much for bo

MULN

newmedman 11 minutos hace

You know, I've tried to stay far away from this discussion but I have to chime in again. You attacking members of this board upsets me.

You say you've read all our posts and all our recipes but do you ever read your own posts back to yourself? It seems you're the one harping on about

fuagf 11 minutos hace

Excellent.

plexrec 12 minutos hace

EFFFF NO !!!!!!!

AVXL

jxyzobrien 12 minutos hace

mixed
market made higher low
but still in 6 day balance

https://stockcharts.com/c-sc/sc?s=SPY&p=30&b=5&g=0&i=p23808763486&a=1336120611&r=1678310477158

ilovetech 14 minutos hace

That would be a major win, as I'm sure that the cost of eventual combination treatments were anticipated years ago, and not just the cost of DCVAX as a monotherapy. It's absolutely brilliant to imagine that kind foresight, even if only incidental. With so many ongoing combo trials, and chasing bett

NWBO

al44 14 minutos hace

Deadly consequences when judges play president

By Ed Timperlake

Our enemies are not playing games. If the courts help facilitate a deadly strike, then shame on the judge and all those cheering him on.

It appears that a federal judge is determined

misterfishman 15 minutos hace

I like the sound of weeeeeeeeeeeeeeeee. Lol.

ASII

bobby1151 15 minutos hace

OK, why did Sree Koneru become a Board member of Bioelectronics Corp? Maybe he was just bored at Viant Medical "OR ????" C'mon !!!!!!!!!!!!!!!!!!!!!!!

BIEL

stockanalyze 15 minutos hace

the fisher hearing on april 3rd after such a long time on hold is suspect due to timing like lamberth’s recent decision timing. eithey sweeney was asked to close it out or they want shareholders rights to be affirmed. hearing will be telling if they want to loot another 80% of the company into swf a

FNMA

navycmdr 15 minutos hace

so WHY did we have such a nice close Friday ? ... always ask WHY ?

IMHO it was the Treasury Bessent interview talking about the Govt GSE
position being put into the SWF - but WHAT is the GOVT position ?

I think our Friday close was ALSO about the article on this

FNMA

Tendencias Ahora

Listas Principales

Datos

Noticias

Herramientas

Mercados

Descubrir

Hot Features

Follow Feed

Flujo de Opciones

Monitor

Crossject (ALCJ) Cotización

Crossject (ALCJ)

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Acerca de Crossject

ALCJ Últimas noticias

CROSSJECT franchit une étape clé dans la stabilité des lots produits de ZEPIZURE®

CROSSJECT achieves key ZEPIZURE® manufacturing batch stability milestones

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board

Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board

Crossject annonce le renouvellement de Patrick Alexandre et Isabelle Liebschutz dans leurs fonctions de membres d’un nouveau Directoire ressérré

COMPLETION OF THE TRANSACTIONS ANNOUNCED IN DECEMBER 2024 RELATING TO THE AMENDMENT OF THE CONVERTIBLE BONDS SUBSCRIBED BY AN ENTITY AFFILIATED TO HEIGHTS CAPITAL MANAGEMENT, INC. (“HEIGHTS”) AND THE ISSUE OF A SECOND ASSIMILABLE TRANCHE

Réalisation des opérations annoncées en décembre 2024 relatives a la modification des obligations convertibles souscrites par une entité affiliée à Heights Capital Management, Inc. (« Heights ») et l’émission d’une seconde tranche assimilab

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

CROSSJECT franchit une étape clé dans la stabilité des lots produits de ZEPIZURE®

CROSSJECT achieves key ZEPIZURE® manufacturing batch stability milestones

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board

Crossject announces the reappointment of Patrick Alexandre and Isabelle Liebschutz as members of new, streamlined Executive Board

Crossject annonce le renouvellement de Patrick Alexandre et Isabelle Liebschutz dans leurs fonctions de membres d’un nouveau Directoire ressérré

COMPLETION OF THE TRANSACTIONS ANNOUNCED IN DECEMBER 2024 RELATING TO THE AMENDMENT OF THE CONVERTIBLE BONDS SUBSCRIBED BY AN ENTITY AFFILIATED TO HEIGHTS CAPITAL MANAGEMENT, INC. (“HEIGHTS”) AND THE ISSUE OF A SECOND ASSIMILABLE TRANCHE

Réalisation des opérations annoncées en décembre 2024 relatives a la modification des obligations convertibles souscrites par une entité affiliée à Heights Capital Management, Inc. (« Heights ») et l’émission d’une seconde tranche assimilab

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social

Crossject confirms ZEPIZURE® supply chain readiness with another successful ISO audit for Quality Management System

ALCJ - Preguntas Frecuentes

Movimientos

Discusión

Su Consulta Reciente

Empresa

Negocios

Popular

Obtener la aplicación

Quitar anuncios